(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GCFLU

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GCFLU

ST13

US500000079213938

Class

5

Filing

79213938

Registration

5477855

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

02/20/2026

Trademark type

Word

Nice classes

5

Filing date

04/28/2017

Registration date

05/29/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/13/2024

Last transaction

02/20/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

KR

Examiner

LAM, HAI-LY HUYNH

Law office

M30

Current location

POST REGISTRATION

Holders and representatives

Holders

G. C. (pessoa física)

Representatives

Yoon S. Ham Hauptman Ham, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for treating the central nervous system; Radioactive pharmaceutical preparations for in vivo and in vitro diagnostic use; Pharmaceutical preparations for anus; Antibiotic preparations; Hypoglycemic agents; Pharmaceutical preparations for treating blood disorders; Blood plasma; Medicated serums for treatment of hairskin and lips; Serotherapeutic medicines for the treatment and prevention of infectious diseases caused by bacteria or viruses; Pharmaceutical preparations for respiratory organs; Biological preparations for medical or veterinary purposesfor the treatment and prevention of infectious diseases caused by bacteria or viruses; Cultures of microorganisms for medical purposesexcept yeast; Pharmaceutical preparations for treatment of infectious diseases caused by bacteria or viruses; Pharmaceutical preparation for skin care; Human vaccine preparations; Vaccines against flu; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting metabolism; Veterinary preparations for the treatment and prevention of infectious diseases caused by bacteria or viruses; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for urogenital organs; Vitamin preparations; Preparations of trace elements for human and animal usenutritional supplements and vitamins for the treatment and prevention of infectious diseases caused by bacteria or viruses; Crude medicines for the treatment and prevention of infectious diseases caused by bacteria or viruses; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; Steroids; Allergy medications; Nutritional supplementsnutritional supplements in tonic form and for use as alteratives for medical purposes; Pharmaceutical preparations for tumor treatment; Pharmaceutical preparations acting on the central nervous system

Publications

History of USPTO decisions and trademark events.

36 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

02/19/2026

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/01/2026

INPC

INVALIDATION PROCESSED

02/01/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

08/13/2025

C71T

CANCELLED SECTION 71

12/13/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/29/2023

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

04/04/2022

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

11/16/2021

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

03/16/2021

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

03/16/2021

PLGL

ASSIGNED TO PARALEGAL

03/16/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

02/28/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/06/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/14/2018

FIMP

FINAL DISPOSITION PROCESSED

09/14/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/29/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

05/29/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/13/2018

PUBO

PUBLISHED FOR OPPOSITION

03/13/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/21/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/07/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

01/18/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/18/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

01/18/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/18/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/31/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/31/2017

RFNT

REFUSAL PROCESSED BY IB

09/08/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/18/2017

RFRR

REFUSAL PROCESSED BY MPU

08/18/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/17/2017

CNRT

NON-FINAL ACTION WRITTEN

08/16/2017

MAFR

APPLICATION FILING RECEIPT MAILED

08/15/2017

DOCK

ASSIGNED TO EXAMINER

08/11/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/11/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/10/2017

Continuous trademark protection

Get notified about every new filing that threatens GCFLU or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.